MEDIFAST INC
Description
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States and the Asia-Pacific. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
About
CEO
Mr. Daniel R. Chard
Employees
634
Instrument type
Common Stock
Sector
Consumer Cyclical
Industry
Personal Services
MIC code
XNYS
Address
100 International Drive, Baltimore, MD 21202, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 3, 2025 | — | — | — | — |
| Aug 4, 2025 | — | — | — | — |
| Apr 28, 2025 | — | — | — | — |
| Feb 18, 2025 | -0.16 | — | — | — |
| Nov 5, 2024 | -0.28 | 0.35 | 0.63 | -225.00% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 2 | — | 2 |
| Average estimate | — | -0.19 | — | 0.30 |
| Low estimate | — | -0.32 | — | 0.19 |
| High estimate | — | -0.06 | — | 0.41 |
| Last year EPS | — | 0.66 | — | 1.77 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-114.680%
Next qtr. (Mar 2025)
-128.790%
Current year
-81.640%
Next year (Dec 2025)
-83.050%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 1.07B | 1.60B | 1.53B | 934.84M | 713.67M |
| Cost of revenue | 296.20M | 458.16M | 398.49M | 237.03M | 176.81M |
| Gross profit | 775.85M | 1.14B | 1.13B | 697.82M | 536.86M |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 649.45M | 955.61M | 911.36M | 563.66M | 445.82M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 126.40M | 184.81M | 216.24M | 134.16M | 91.04M |
| Non operating interest income | |||||
| Income | 2.49M | — | — | 246,000 | 1.30M |
| Expense | — | 701,000 | — | — | — |
| Other income expense | -95,000 | -46,000 | 119,000 | -140,000 | 29,000 |
| Pretax income | 128.80M | 184.06M | 216.13M | 134.27M | 92.36M |
| Tax provision | 29.38M | 40.49M | 52.10M | 31.41M | 14.45M |
| Net income | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M |
| Basic EPS | 9.10 | 12.82 | 14.01 | 8.74 | 6.62 |
| Diluted EPS | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 |
| Basic average shares | 10.88M | 11.20M | 11.71M | 11.77M | 11.77M |
| Diluted average shares | 10.88M | 11.20M | 11.71M | 11.77M | 11.77M |
| EBITDA | 139.51M | 195.74M | 223.05M | 138.48M | 95.66M |
| Net income from continuing op. | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 309.91M | 316.21M | 398.33M | 276.08M | 194.65M |
| Current assets | |||||
| Cash | 88.78M | 87.69M | 94.82M | 159.75M | 36.59M |
| Cash equivalents | 5.66M | — | 9.36M | 3.97M | 40.38M |
| Cash and cash equivalents | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M |
| Other short term investments | 55.60M | — | 5.36M | 10.75M | 15.70M |
| Accounts receivable | — | — | — | 584,000 | 1.44M |
| Other receivables | — | — | — | — | — |
| Inventory | 54.59M | 118.86M | 180.04M | 53.39M | 48.77M |
| Prepaid assets | 8.73M | — | 945,000 | 6.45M | 11.27M |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 10.67M | 16.24M | 16.33M | — | — |
| Non current assets | |||||
| Properties | 15.65M | 18.46M | 24.46M | 10.51M | 12.80M |
| Land and improvements | 565,000 | 565,000 | 565,000 | 565,000 | 565,000 |
| Machinery furniture equipment | 73.71M | 70.66M | 64.75M | 41.15M | 35.60M |
| Construction in progress | — | — | — | — | — |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -47.31M | -39.94M | -32.70M | -27.09M | -23.02M |
| Goodwill | — | — | — | — | — |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 18.77M | 17.78M | 10.87M | 3.63M | 1.66M |
| Total liabilities | 108.43M | 161.17M | 195.85M | 118.84M | 89.82M |
| Current liabilities | |||||
| Accounts payable | 39.19M | 53.12M | 70.89M | 36.09M | 22.61M |
| Accrued expenses | 22.11M | 23.82M | 35.88M | 24.57M | 20.83M |
| Short term debt | 5.89M | 5.78M | 6.52M | 3.67M | 3.17M |
| Deferred revenue | 574,000 | 7.36M | 8.05M | 7.61M | 4.33M |
| Tax payable | 9.86M | 7.55M | 2.57M | 2.98M | 1.55M |
| Pensions | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — |
| Non current liabilities | |||||
| Long term debt | 16.13M | 20.28M | 26.02M | 7.49M | 10.43M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | — | — | — | — | — |
| Shareholders equity | |||||
| Common stock | 11,000 | 11,000 | 12,000 | 12,000 | 12,000 |
| Retained earnings | 174.65M | 139.85M | 190.33M | 154.35M | 168.79M |
| Other shareholders equity | 248,000 | 24,000 | 111,000 | 41,000 | 25,000 |
| Total shareholders equity | 201.48M | 155.04M | 202.47M | 157.25M | 104.83M |
| Additional paid in capital | 26.57M | 21.56M | 12.02M | 7.84M | — |
| Treasury stock | — | 6.40M | — | 5.00M | 63.99M |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | 99.42M | 143.57M | 164.03M | 102.86M | 77.92M | 55.79M | 27.72M | 17.84M | 19.57M | 21.03M | 27.14M | 18.44M | 18.54M | 19.61M | 11.36M | 4.83M | 3.84M | 5.08M | 2.73M | 1.75M | 2.41M | 2.62M | 588,000 | 1.30M | -3.19M | -949,000 | -3.70M | 320,000 |
| Depreciation | 13.11M | 10.98M | 6.81M | 4.32M | 4.62M | 4.44M | 4.21M | 5.41M | 7.12M | 8.05M | 7.90M | 8.39M | 8.34M | 5.86M | 5.27M | 4.57M | 3.47M | 2.40M | 1.74M | 1.21M | 648,000 | 321,000 | 211,000 | 219,000 | 232,000 | 431,000 | 875,000 | 662,000 |
| Deferred Taxes | 1.21M | -924,000 | -3.72M | 601,000 | 1.60M | -2.69M | -623,000 | -2.83M | -106,000 | 286,000 | 428,000 | -598,000 | 6.02M | -70,000 | -218,000 | -234,000 | -390,000 | -648,000 | 301,000 | 486,000 | 1.14M | -925,000 | -22,000 | -787,000 | — | — | — | — |
| Stock-Based Compensation | 8.19M | 11.05M | 9.90M | 6.80M | 4.52M | 3.12M | 4.27M | 3.43M | 3.08M | 3.92M | 3.21M | 2.85M | 2.52M | 2.63M | 2.36M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | 4.61M | 6.10M | 5.07M | 3.19M | 2.62M | — | — | — | — | — | 3.21M | — | 18.54M | 50,000 | 2.00M | 1.47M | 811,000 | 703,000 | — | — | — | — | — | — | — | 191,000 | 907,000 | -57,000 |
| Accounts Receivable | — | — | — | 297,000 | -4.06M | -936,000 | 664,000 | 246,000 | 17,000 | -708,000 | 87,000 | -389,000 | -854,000 | 53,000 | -228,000 | 43,000 | -43,000 | 379,000 | 65,000 | -422,000 | -357,000 | -1,000 | -31,000 | 56,000 | 137,000 | -2.23M | 443,000 | -641,000 |
| Accounts Payable | -35.71M | -37.59M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Assets & Liabilities | 50.42M | 59.15M | -132.14M | -2.19M | -17.67M | -16.32M | -3.92M | -4.63M | 6.24M | -3.71M | 4.33M | 3.98M | -3.57M | -8.37M | 899,000 | -6.09M | -1.06M | -3.64M | -1.26M | -614,000 | -2.01M | -420,000 | -3,000 | -242,000 | 1.07M | -321,000 | 137,000 | -804,000 |
| Operating Cash Flow | 141.24M | 192.33M | 49.96M | 115.87M | 69.55M | 43.40M | 32.32M | 19.45M | 35.92M | 28.86M | 46.30M | 32.67M | 49.54M | 19.76M | 21.43M | 4.60M | 6.63M | 4.28M | 3.58M | 2.41M | 1.83M | 1.60M | 743,000 | 549,000 | -1.75M | -2.88M | -1.34M | -520,000 |
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | -6.48M | -16.68M | -34.21M | -5.89M | -10.06M | -4.74M | -3.16M | -2.20M | -2.82M | -7.02M | -11.39M | -8.13M | -14.27M | -12.06M | -5.12M | -7.43M | -7.97M | -7.98M | -1.67M | -2.06M | -3.13M | -3.97M | -46,000 | -123,000 | -28,000 | -200,000 | 2.32M | -216,000 |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | -387,000 | — | -235,000 | -13,000 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | -54.56M | — | — | — | — | — | -6.96M | -26.58M | -9.25M | -26.08M | -25.36M | -8.39M | -10.28M | -16.97M | -4.44M | — | -4,000 | — | -84,000 | -112,000 | -3.56M | -409,000 | -200,000 | -200,000 | — | — | — | — |
| Sale of Investments | — | 5.27M | 5.15M | 4.61M | 3.73M | 3.55M | 6.95M | 26.74M | 11.88M | 29.64M | 14.36M | 8.11M | 8.06M | 5.49M | 1.18M | 129,000 | — | 1.24M | — | 1.34M | 418,000 | 319,000 | 100,000 | — | — | — | — | — |
| Investing Cash Flow | -61.05M | -11.41M | -29.06M | -1.28M | -6.33M | -1.20M | -3.16M | -2.04M | -189,000 | -3.47M | -22.38M | -8.41M | -16.49M | -23.54M | -8.38M | -7.30M | -7.97M | -6.75M | -2.03M | -3.62M | -8.74M | -4.57M | -146,000 | -323,000 | -28,000 | -200,000 | 2.32M | -934,000 |
| Financing Activities | ||||||||||||||||||||||||||||
| Long-Term Debt Issuance | — | — | — | — | — | — | — | — | — | — | — | — | — | 393,000 | 2.77M | 132,000 | — | — | — | — | — | — | — | — | — | 5.26M | 1.64M | 662,000 |
| Long-Term Debt Payments | — | — | — | — | — | — | — | -219,000 | -255,000 | -222,000 | -3.64M | -1.44M | -1.14M | -834,000 | -930,000 | -264,000 | — | — | — | — | — | — | — | — | — | -3.70M | -2.02M | -459,000 |
| Other Financing Charges | — | — | — | — | — | — | — | 230,000 | 292,000 | 327,000 | 409,000 | 1.28M | 626,000 | 1.78M | -2.86M | 132,000 | 98,000 | -14,000 | — | — | 150,000 | — | — | — | — | — | — | — |
| Financing Cash Flow | -79.98M | -199.58M | -125.94M | -58.74M | -82.60M | -53.88M | -17.93M | -13.22M | -11.78M | -34.94M | -23.31M | -2.93M | -20.90M | 1.33M | -4.07M | 1.60M | 5,000 | 361,000 | -397,000 | -4,000 | 6.68M | -85,000 | 28,000 | 74,000 | -51,000 | 2.47M | -451,000 | 1.09M |
| Other Cash Details | ||||||||||||||||||||||||||||
| End Cash Position | 94.44M | 87.69M | 104.18M | 163.72M | 76.97M | 81.36M | 75.08M | 52.44M | 42.04M | 24.46M | 36.38M | 39.94M | 14.26M | 17.17M | 10.60M | 1.84M | 2.20M | 1.09M | 1.48M | 612,000 | 2.52M | 837,000 | 270,000 | 102,000 | 154,000 | 503,000 | 255,000 | 286,000 |
| Income Tax Paid | 34.26M | 37.21M | 56.76M | 24.64M | 17.31M | 14.61M | 13.62M | 11.62M | 4.18M | 12.72M | 9.98M | 4.09M | 4.13M | 10.68M | 9.17M | 3.66M | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | — | — | — | — | — | — | — | 24,000 | 22,000 | 131,000 | 57,000 | 123,000 | 96,000 | 111,000 | 145,000 | 367,000 | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 141.17M | 177.89M | 60.34M | 139.31M | 74.20M | 55.88M | 40.00M | 22.47M | 26.59M | 18.51M | 30.97M | 32.14M | 20.21M | 16.71M | 13.80M | -1.95M | -11,000 | -2.14M | 1.54M | -154,000 | -1.26M | -1.52M | 605,000 | -145,000 | -176,000 | -2.24M | -2.06M | -494,000 |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 356,866 | 5.52M | 3.26% |
| iShares Russell 2000 ETF | Nov 30, 2024 | 317,537 | 4.91M | 2.90% |
| Avantis U.S. Small Cap Value ETF | Nov 30, 2024 | 211,414 | 3.27M | 1.93% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 162,005 | 2.51M | 1.48% |
| Federated Hermes MDT Small Cap Core Fund | Oct 31, 2024 | 125,563 | 1.94M | 1.15% |
| Vanguard Consumer Staples Index Fund | Nov 30, 2024 | 120,112 | 1.86M | 1.10% |
| iShares Russell 2000 Value ETF | Nov 30, 2024 | 111,247 | 1.72M | 1.02% |
| Fidelity Small Cap Index Fund | Oct 31, 2024 | 107,701 | 1.67M | 0.98% |
| Hotchkis and Wiley Small Cap Diversified Value Fund | Dec 31, 2024 | 89,500 | 1.38M | 0.82% |
| Federated Hermes MDT Mid Cap Growth Fund | Oct 31, 2024 | 82,002 | 1.27M | 0.75% |
Article
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chie.
Feb 4, 2025
Article
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges
With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.
Jan 22, 2025
Article
Medifast Launches OPTAVIA ASCEND for Weight Loss Management
MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.
Jan 8, 2025
